Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy

被引：0
|
作者：
Kramer-Marek, G. [1 ]
Maczynska, J. [1 ]
Raes, F. [1 ]
Malarz, K. [2 ]
Da Pieve, C. [1 ]
de Mezer, M. [3 ]
Niedbala, M. [4 ]
Harrington, K. J. [1 ]
Kaspera, W. [4 ]
机构：
[1] Inst Canc Res, Radiotherapy & Imaging, Sutton, Surrey, England
[2] Univ Silesia, Silesian Ctr Educ & Interdisciplinary Res, Chorzow, Poland
[3] Adam Mickiewicz Univ, Ctr Adv Technol, Poznan, Poland
[4] Med Univ Silesia, Dept Neurosurg, Reg Hosp, Sosnowiec, Poland
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
421P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease
    Deegens, JKJ
    Artz, MA
    Hoitsma, AJ
    Wetzels, JFM
    CLINICAL NEPHROLOGY, 2003, 59 (01) : 1 - 9
  • [22] A Rare Case of Atypical IgA-Mediated Anti-GBM Disease with ANCA-Associated Glomerulonephritis
    Nasr, Kristina Karim
    Pickthorn, Sean
    Klomjit, Nattawat
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [23] Panitumumab interacts with TAS-102 leading to combinational anti-cancer effects by blocking EGFR-mediated tumor response to trifluridine
    Nakamura, Kazuhide
    Baba, Yuji
    Tamura, Toshiya
    Satoh, Yoshihiko
    Gotou, Masamitsu
    Sawada, Hiroshi
    Ebara, Shunsuke
    Shibuya, Kazunori
    Soeda, Jumpei
    CANCER RESEARCH, 2017, 77
  • [24] Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells
    Unson, Sukanya
    Chang, Tung-Cheng
    Yang, Yung-Ning
    Wang, Shwu-Huey
    Huang, Chi-Hung
    Crawford, Dana R.
    Huang, Haw-Ming
    Li, Zi-Lin
    Lin, Hung-Yun
    Whang-Peng, Jacqueline
    Wang, Kuan
    Davis, Paul J.
    Li, Wen-Shan
    MARINE DRUGS, 2022, 20 (08)
  • [25] ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells
    Kol, Arjan
    van Scheltinga, Anton Terwisscha
    Pool, Martin
    Gerdes, Christian
    de Vries, Elisabeth
    de Jong, Steven
    ONCOTARGET, 2017, 8 (28) : 45432 - 45446
  • [26] Diverse genetic backgrounds determines EGFR mediated response to erlotinib in GBM cell lines
    Kratovac, Sebila
    Ayuso-Sacido, Angel
    Boockvar, John
    NEURO-ONCOLOGY, 2007, 9 (04) : 475 - 475
  • [27] CIRCULATING ANTI-GBM ANTIBODY AND IMMUNE-COMPLEXES IN MERCURIC CHLORIDE-INDUCED NEPHRITIS IN THE BROWN NORWAY RAT
    BOWMAN, C
    LOCKWOOD, CM
    AMOS, N
    PETERS, DK
    KIDNEY INTERNATIONAL, 1981, 20 (05) : 686 - 686
  • [28] Gene expression profiling of anti-GBM glomerulonephritis model:: The role of NF-κB in immune complex kidney disease
    Kim, JH
    Ha, IS
    Hwang, CI
    Lee, YJ
    Kim, J
    Yang, SH
    Kim, YS
    Cao, YA
    Choi, S
    Park, WY
    KIDNEY INTERNATIONAL, 2004, 66 (05) : 1826 - 1837
  • [29] Fractionated photoimmunotherapy stimulates an anti-tumour immune response: an integrated mathematical and in vitro study
    Zahid, Mohammad U.
    Waguespack, Matthew
    Harman, Rebecca C.
    Kercher, Eric M.
    Nath, Shubhankar
    Hasan, Tayyaba
    Rizvi, Imran
    Spring, Bryan Q.
    Enderling, Heiko
    BRITISH JOURNAL OF CANCER, 2024, 131 (08) : 1378 - 1386
  • [30] MANIPULATION OF THE SPLENIC PLAQUE-FORMING CELL (PFC) RESPONSE IN HGCL2-INDUCED ANTI-GBM DISEASE
    SAVIGE, JA
    LOCKWOOD, CM
    KIDNEY INTERNATIONAL, 1985, 28 (02) : 275 - 275
12345